Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
6-phosphofructokinase deficiency
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
6-phosphofructokinase deficiency
Congenital and metabolic myopathies of childhood or adult onset.
6-phosphofructokinase deficiency
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
6-phosphofructokinase deficiency
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
6-phosphofructokinase deficiency
Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease).
6-phosphofructokinase deficiency
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
6-phosphofructokinase deficiency
Myopathies due to enzyme deficiencies.
6-phosphofructokinase deficiency
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
6-phosphofructokinase deficiency
Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
6-phosphofructokinase deficiency
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Acidosis
31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
Acidosis
Effect of induced metabolic acidosis on human skeletal muscle metabolism during exercise.
Acidosis
Metabolic and energy correlates of intracellular pH in progressive fatigue of squid (L. brevis) mantle muscle.
Acidosis
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Acidosis, Lactic
Convulsions as the etiology of lactic acidosis in acute diazinon toxicity in rats.
Acidosis, Respiratory
Skeletal muscle lactate release and glycolytic intermediates during hypercapnia.
Acute Coronary Syndrome
Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary Syndrome.
Acute Coronary Syndrome
Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.
Acute Coronary Syndrome
Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation.
Acute Coronary Syndrome
Glycogen phosphorylase BB in acute coronary syndromes.
Acute Coronary Syndrome
Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
Acute Coronary Syndrome
Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome.
Acute Coronary Syndrome
PP054. Elevated maternal plasma glycogen phosphorylase isoenzyme BB as time of disease biomarker of pre-eclampsia and small-for-gestational-age.
Acute Coronary Syndrome
Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome.
Acute Coronary Syndrome
The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome.
Acute Coronary Syndrome
Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method.
Acute Kidney Injury
Acute renal failure in McArdle's disease.
Acute Kidney Injury
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Acute Kidney Injury
[Rhabdomyolysis due to muscle enzyme deficiencies]
Adenocarcinoma
BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer.
Adenocarcinoma
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
Alkalosis
Effect of induced metabolic alkalosis on human skeletal muscle metabolism during exercise.
Alopecia
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
amidase deficiency
Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.
amp deaminase deficiency
Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: a second case of 'double trouble'.
amp deaminase deficiency
Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci.
amylo-alpha-1,6-glucosidase deficiency
Myopathies due to enzyme deficiencies.
amylo-alpha-1,6-glucosidase deficiency
Pathological characteristics of glycogen storage disease III in skeletal muscle.
Anaphylaxis
Histochemical investigations on phosphorylase, branching enzyme and glycogen in guinea pig livers in experimental anaphylactic and histaminic shock.
Angina, Stable
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
Angina, Unstable
Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations.
Angina, Unstable
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
Angina, Unstable
[Effect of corinfar on the dynamic function and various indices of glycolysis and glycogenolysis in the thrombocytes of patients with unstable stenocardia]
Anthrax
Identification of Alzheimer's Disease Autoantibodies and Their Target Biomarkers by Phage Microarrays.
Arthrogryposis
Fatal arthrogryposis with respiratory insufficiency: a possible case of muscle phosphorylase b-kinase deficiency.
Astrocytoma
Beta adrenergic regulation of glycogen phosphorylase activity and adenosine cyclic 3', 5'-monophosphate accumulation in control and desensitized C-6 astrocytoma cells.
Astrocytoma
Human astrocytoma U251 RNA and genomic brain glycogen phosphorylase sequences.
Astrocytoma
Human brain glycogen phosphorylase. Cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes.
Ataxia Telangiectasia
Linkage studies of NIDDM with 23 chromosome 11 markers in a sample of whites of northern European descent.
Blister
Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
Blister
The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+.
Blister
Toxicity of the antiandrogen flutamide in isolated rat hepatocytes.
Brain Diseases
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Breast Neoplasms
Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.
Breast Neoplasms
Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Carcinogenesis
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Carcinogenesis
Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Carcinogenesis
Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
Carcinogenesis
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Carcinogenesis
Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Carcinoma
Antigen reversion of glycogen phosphorylase isoenzyme in carcinoma and proliferative zone of intestinal metaplasia of the human stomach. An immunohistochemical study.
Carcinoma
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Carcinoma
Elevated concentrations of brain-type glycogen phosphorylase in renal cell carcinoma.
Carcinoma
Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Carcinoma
Expression of glycogen phosphorylase activity in minute gastric carcinoma.
Carcinoma
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
Carcinoma
Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Carcinoma
Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
Carcinoma
Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Carcinoma
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Carcinoma
Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Carcinoma
Nuclear localization of brain-type glycogen phosphorylase in some gastrointestinal carcinoma.
Carcinoma in Situ
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Carcinoma, Hepatocellular
Carcinofetal alterations in glycogen phosphorylase isozymes in rat hepatomas.
Carcinoma, Hepatocellular
Disc electrophoretic study of the glycogen phosphorylase in ascites hepatoma. Its comparison with phosphorylases in fetal and adult rat livers and muscles.
Carcinoma, Hepatocellular
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Carcinoma, Hepatocellular
Glycogen phosphorylase isoenzymes from hepatoma 3924A and from a non-tumorigenic liver cell line. Comparison with the liver and brain enzymes.
Carcinoma, Hepatocellular
Isozyme patterns of glycogen phosphorylase in rat tissues and transplantable hepatomas.
Carcinoma, Hepatocellular
Particulate-associated protein phosphatases of rat hepatomas as compared with the enzymes of rat liver.
Carcinoma, Hepatocellular
Resolution of glycogen phosphorylase isoenzymes in precast PhastSystem polyacrylamide gels.
Carcinoma, Hepatocellular
Studies on responsiveness of hepatoma cells to catecholamines. IV. Lack of adrenergic activation of phosphorylase in rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Studies on responsiveness of hepatoma cells to catecholamines. V. Loss of adrenergic response of glycogen phosphorylase in rat ascites hepatoma AH130 cells.
Carcinoma, Non-Small-Cell Lung
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
Carcinoma, Non-Small-Cell Lung
Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Carcinoma, Renal Cell
Elevated concentrations of brain-type glycogen phosphorylase in renal cell carcinoma.
Cardiomegaly
Effect of acute ischemia on myocardial cyclic AMP, phosphorylase a, and lactate levels in various forms of cardiac hypertrophy. Correlation with cardiac norepinephrine stores.
Cardiomyopathies
Absence of myophosphorylase in ethanol induced cardiomyopathy.
Cardiomyopathies
Enzyme pattern in endomyocardial biopsies from patients with chronic heart diseases.
Cardiomyopathy, Hypertrophic
Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy.
Cardiotoxicity
Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities.
Cardiotoxicity
Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation.
Cardiotoxicity
Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation.
Cardiotoxicity
Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.
Cardiotoxicity
Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies.
Cardiotoxicity
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity.
Cardiotoxicity
Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity.
Cardiotoxicity
Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation.
Cardiotoxicity
The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
Cardiotoxicity
Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.
Cardiovascular Diseases
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
Cardiovascular Diseases
Thymidine phosphorylase: A potential new target for treating cardiovascular disease.
carnitine o-palmitoyltransferase deficiency
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
carnitine o-palmitoyltransferase deficiency
[Rhabdomyolysis due to muscle enzyme deficiencies]
Cholera
Post-receptor defect accounts for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.
Colonic Neoplasms
Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma.
Colonic Neoplasms
Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Colorectal Neoplasms
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Colorectal Neoplasms
Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Colorectal Neoplasms
Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Colorectal Neoplasms
Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Colorectal Neoplasms
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Conjunctivitis
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Contracture
A new variant of late-onset myophosphorylase deficiency.
Contracture
Isoproterenol-induced relaxation, phosphorylase activation and cylic adenosine monophosphate levels in the polarized and depolarized rat uterus.
Contracture
PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
Coronary Occlusion
[Action of dopamine on glucose level and glycogen phosphorylase activity of blood plasma in experimental coronary occlusion]
Cysts
Amoebicidal activity of caffeine and maslinic acid by the induction of Programmed Cell Death in Acanthamoeba.
Cysts
siRNA-loaded liposomes: Inhibition of encystment of Acanthamoeba and toxicity on the eye surface.
Cysts
The therapeutic potential of a combination of two gene-specific siRNAs against clinical strains of Acanthamoeba.
Cysts
Toxoplasma gondii Requires Glycogen Phosphorylase for Balancing Amylopectin Storage and for Efficient Production of Brain Cysts.
Cytochrome-c Oxidase Deficiency
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
Diabetes Mellitus
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Diabetes Mellitus
Expression of the gene encoding glycogen phosphorylase is elevated in diabetic rat skeletal muscle and is regulated by insulin and cyclic AMP.
Diabetes Mellitus
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
Diabetes Mellitus
Inhibition of brain-type glycogen phosphorylase ameliorates high glucose-induced cardiomyocyte apoptosis via Akt-HIF-1? activation.
Diabetes Mellitus, Experimental
Changes in the activity of enzymes, participating in glycogen metabolism of alloxan diabetic rats.
Diabetes Mellitus, Experimental
[Effect of trihydroxyoctadecadiene acids from Bryonia alba L. on the activity of glycogen metabolism enzymes in alloxan diabetes]
Diabetes Mellitus, Type 1
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL).
Diabetes Mellitus, Type 2
1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Diabetes Mellitus, Type 2
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
Diabetes Mellitus, Type 2
Anomeric Spironucleosides of ?-d-Glucopyranosyl Uracil as Potential Inhibitors of Glycogen Phosphorylase.
Diabetes Mellitus, Type 2
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Diabetes Mellitus, Type 2
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Diabetes Mellitus, Type 2
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Diabetes Mellitus, Type 2
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.
Diabetes Mellitus, Type 2
Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
Diabetes Mellitus, Type 2
Computation as a Tool for Glycogen Phosphorylase Inhibitor Design.
Diabetes Mellitus, Type 2
Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution.
Diabetes Mellitus, Type 2
Defects in liver and muscle glycogen metabolism in neonatal and adult New Zealand obese mice.
Diabetes Mellitus, Type 2
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Diabetes Mellitus, Type 2
Evidence against glycogen cycling of gluconeogenic substrates in various liver preparations.
Diabetes Mellitus, Type 2
FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. I. Taxonomy, fermentation, isolation and biological activities.
Diabetes Mellitus, Type 2
Glucokinase and molecular aspects of liver glycogen metabolism.
Diabetes Mellitus, Type 2
Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
Diabetes Mellitus, Type 2
Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
Diabetes Mellitus, Type 2
Glycogen phosphorylase as a molecular target for type 2 diabetes therapy.
Diabetes Mellitus, Type 2
Glycogen phosphorylase as a target for type 2 diabetes: synthetic, biochemical, structural and computational evaluation of novel N-acyl-N´-(?-D-glucopyranosyl) urea inhibitors.
Diabetes Mellitus, Type 2
Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
Diabetes Mellitus, Type 2
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
Diabetes Mellitus, Type 2
Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Inhibition of brain-type glycogen phosphorylase ameliorates high glucose-induced cardiomyocyte apoptosis via Akt-HIF-1? activation.
Diabetes Mellitus, Type 2
Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site.
Diabetes Mellitus, Type 2
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Diabetes Mellitus, Type 2
Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.
Diabetes Mellitus, Type 2
Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.
Diabetes Mellitus, Type 2
Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase.
Diabetes Mellitus, Type 2
New inhibitors of glycogen phosphorylase as potential antidiabetic agents.
Diabetes Mellitus, Type 2
Novel Liver-targeted conjugates of Glycogen Phosphorylase Inhibitor PSN-357 for the Treatment of Diabetes: Design, Synthesis, Pharmacokinetic and Pharmacological Evaluations.
Diabetes Mellitus, Type 2
Optimization and Validation of an In Vitro Standardized Glycogen Phosphorylase Activity Assay.
Diabetes Mellitus, Type 2
Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
Diabetes Mellitus, Type 2
Physiological Control of Liver Glycogen Metabolism: Lessons from Novel Glycogen Phosphorylase Inhibitors.
Diabetes Mellitus, Type 2
Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes.
Diabetes Mellitus, Type 2
Probing the ?-pocket of the active site of human liver glycogen phosphorylase with 3-(C-?-d-glucopyranosyl)-5-(4-substituted-phenyl)-1, 2, 4-triazole inhibitors.
Diabetes Mellitus, Type 2
Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.
Diabetes Mellitus, Type 2
Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: Comparison of chrysin and flavopiridol.
Diabetes Mellitus, Type 2
Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-?-d-glucopyranosylamines.
Diabetes Mellitus, Type 2
Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors.
Diabetes Mellitus, Type 2
Synthesis of 5-halogenated 1,2,3-triazoles under stoichiometric Cu(I)-mediated azide-alkyne cycloaddition (CuAAC or 'Click Chemistry').
Diabetes Mellitus, Type 2
Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor.
Diabetes Mellitus, Type 2
Synthesis of N-Glucopyranosidic Derivatives as Potential Inhibitors that Bind at the Catalytic Site of Glycogen Phosphorylase.
Diabetes Mellitus, Type 2
Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(?-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase.
Diabetes Mellitus, Type 2
The binding of ?-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
Diabetes Mellitus, Type 2
The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
Diabetes Mellitus, Type 2
The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
Diabetes Mellitus, Type 2
Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
Dyspnea
McArdle's disease presenting as unexplained dyspnea in a young woman.
Ectropion
Ectropion and epiphora in McArdle's syndrome.
Eczema
[Erythrocyte phosphorylase A activity in eczema]
Endometrial Neoplasms
Hormone dependency of carcinoma of the human endometrium. Effect of progesterone on glycogen metabolism in the carcinoma tissue.
Endometrial Neoplasms
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
Endometriosis
Endometriosis impairs glycogen synthesis in human endometrium.
Endotoxemia
Alterations in binding of inositol 1,4,5-trisphosphate to subcellular structures of rat liver during chronic endotoxemia.
Endotoxemia
Glycogen synthase and phosphorylase activities during glycogen repletion in endotoxemic rats.
Endotoxemia
Perturbation of transmembrane signaling mechanisms in acute and chronic endotoxemia.
Endotoxemia
Shift from alpha- to beta-type adrenergic receptor-mediated responses in chronically endotoxemic rats.
Foot-and-Mouth Disease
Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli.
Fructose Intolerance
Decrease and inhibition of liver glycogen phosphorylase after fructose. An experimental model for the study of hereditary fructose intolerance.
Genetic Diseases, Inborn
Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.
Glioma
Calmodulin inhibitors activate glycogen phosphorylase B to A conversion in C6 glioma cells.
glucan 1,4-alpha-glucosidase deficiency
Congenital and metabolic myopathies of childhood or adult onset.
glucan 1,4-alpha-glucosidase deficiency
Glycogen storage diseases of muscle.
glucan 1,4-alpha-glucosidase deficiency
Myopathies due to enzyme deficiencies.
glucan 1,4-alpha-glucosidase deficiency
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
glycogen phosphorylase deficiency
31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
glycogen phosphorylase deficiency
A direct StyI polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) test for the myophosphorylase mutation in cattle.
glycogen phosphorylase deficiency
A new stop codon mutation (Y52X) in the myophosphorylase gene in a Greek patient with McArdle's disease.
glycogen phosphorylase deficiency
A new variant of late-onset myophosphorylase deficiency.
glycogen phosphorylase deficiency
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease.
glycogen phosphorylase deficiency
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
glycogen phosphorylase deficiency
A thermodynamic function of glycogen in brain and muscle.
glycogen phosphorylase deficiency
Absence of biochemical heterogeneity in McArdle's disease. A high resolution SDS-polyacrylamide gel electrophoresis study.
glycogen phosphorylase deficiency
Absence of exercise-induced MRI enhancement of skeletal muscle in McArdle's disease.
glycogen phosphorylase deficiency
Acute renal failure in McArdle's disease.
glycogen phosphorylase deficiency
Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
glycogen phosphorylase deficiency
Aerobic conditioning: an effective therapy in McArdle's disease.
glycogen phosphorylase deficiency
An A-to-C substitution involving the translation initiation codon in a patient with myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
glycogen phosphorylase deficiency
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
glycogen phosphorylase deficiency
ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
glycogen phosphorylase deficiency
Changes in force and intracellular metabolites during fatigue of human skeletal muscle.
glycogen phosphorylase deficiency
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
glycogen phosphorylase deficiency
Clinical spectrum of McArdle disease: three cases with unusual expression.
glycogen phosphorylase deficiency
Clinical utility gene card for McArdle disease.
glycogen phosphorylase deficiency
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
glycogen phosphorylase deficiency
Congenital and metabolic myopathies of childhood or adult onset.
glycogen phosphorylase deficiency
Congenital myopathy due to phosphorylase deficiency.
glycogen phosphorylase deficiency
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
glycogen phosphorylase deficiency
Depot-glucagon in the treatment of McArdle's disease.
glycogen phosphorylase deficiency
Diagnosis of McArdle's disease by molecular genetic analysis of blood.
glycogen phosphorylase deficiency
Differential glucose metabolism in mice and humans affected by McArdle disease.
glycogen phosphorylase deficiency
Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
glycogen phosphorylase deficiency
Dominant inheritance of McArdle syndrome.
glycogen phosphorylase deficiency
Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
glycogen phosphorylase deficiency
Ectropion and epiphora in McArdle's syndrome.
glycogen phosphorylase deficiency
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
glycogen phosphorylase deficiency
Electrophysiologic and histochemical observations in five patients with muscle phosphorylase deficiency (MPD).
glycogen phosphorylase deficiency
Exercise induced fatigue: unfit or unwell?
glycogen phosphorylase deficiency
Exercise tolerance and daily life in McArdle's disease.
glycogen phosphorylase deficiency
Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
glycogen phosphorylase deficiency
Fasting as a provocative test in neuromuscular diseases.
glycogen phosphorylase deficiency
Fat metabolism during exercise in patients with McArdle disease.
glycogen phosphorylase deficiency
Fatal infantile form of muscle phosphorylase deficiency.
glycogen phosphorylase deficiency
Fatal infantile muscle phosphorylase deficiency.
glycogen phosphorylase deficiency
Fatigue in human metabolic myopathy.
glycogen phosphorylase deficiency
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
glycogen phosphorylase deficiency
Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation.
glycogen phosphorylase deficiency
Genetic deficiencies of the glycogen phosphorylase system.
glycogen phosphorylase deficiency
Genetic test for myophosphorylase deficiency in Charolais cattle.
glycogen phosphorylase deficiency
Genotype modulators of clinical severity in McArdle disease.
glycogen phosphorylase deficiency
Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
glycogen phosphorylase deficiency
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
glycogen phosphorylase deficiency
Glycogen storage diseases of muscle.
glycogen phosphorylase deficiency
Glycogenosis type V (McArdle's disease) mimicking atypical myositis.
glycogen phosphorylase deficiency
Higher oxidative stress in skeletal muscle of McArdle disease patients.
glycogen phosphorylase deficiency
Histochemical and biochemical studies in a patient with myophosphorylase deficiency.
glycogen phosphorylase deficiency
HyperCKemia as the only sign of McArdle's disease in a child.
glycogen phosphorylase deficiency
Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
glycogen phosphorylase deficiency
Immunological studies on glycogen storage diseases type 3 and V. Demonstration of the presence of an immunoreactive protein in one case of muscle phosphorylase deficiency.
glycogen phosphorylase deficiency
Impaired aerobic glycolysis in muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in 31P magnetic resonance spectroscopy.
glycogen phosphorylase deficiency
Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
glycogen phosphorylase deficiency
Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.
glycogen phosphorylase deficiency
Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
Increased PFK activity and GLUT4 protein content in McArdle's disease.
glycogen phosphorylase deficiency
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
glycogen phosphorylase deficiency
Internal restriction sites: quality assurance aids in genotyping.
glycogen phosphorylase deficiency
Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease).
glycogen phosphorylase deficiency
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
glycogen phosphorylase deficiency
Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
glycogen phosphorylase deficiency
Lactate production in McArdle's disease.
glycogen phosphorylase deficiency
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI.
glycogen phosphorylase deficiency
Liver glycogen phosphorylase deficiency.
glycogen phosphorylase deficiency
Low muscle levels of pyridoxine in McArdle's syndrome.
glycogen phosphorylase deficiency
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
glycogen phosphorylase deficiency
McArdle disease: a novel mutation in Jewish families from the Caucasus region.
glycogen phosphorylase deficiency
McArdle Disease: A Unique Study Model in Sports Medicine.
glycogen phosphorylase deficiency
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
glycogen phosphorylase deficiency
McArdle's disease presenting as treatment resistant polymyositis.
glycogen phosphorylase deficiency
McArdle's disease presenting as unexplained dyspnea in a young woman.
glycogen phosphorylase deficiency
McArdle's disease presenting with asymmetric, late-onset arm weakness.
glycogen phosphorylase deficiency
McArdle's disease resembling an inflammatory myopathy.
glycogen phosphorylase deficiency
McArdle's disease with late-onset symptoms: case report and review of the literature.
glycogen phosphorylase deficiency
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
glycogen phosphorylase deficiency
McArdle's disease-muscle glycogen phosphorylase deficiency.
glycogen phosphorylase deficiency
Mcardle's disease. A case report.
glycogen phosphorylase deficiency
McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiency.
glycogen phosphorylase deficiency
McArdle's disease: case report and review of the literature.
glycogen phosphorylase deficiency
Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
glycogen phosphorylase deficiency
Metabolic control of cardiac output response to exercise in McArdle's disease.
glycogen phosphorylase deficiency
Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease.
glycogen phosphorylase deficiency
Molecular characterization of McArdle's disease in two large Finnish families.
glycogen phosphorylase deficiency
Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
glycogen phosphorylase deficiency
Molecular characterization of myophosphorylase deficiency in a group of patients from northern Italy.
glycogen phosphorylase deficiency
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
Molecular genetic study of myophosphorylase deficiency (McArdle's disease) in two Yemenite-Jewish families.
glycogen phosphorylase deficiency
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
glycogen phosphorylase deficiency
Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.
glycogen phosphorylase deficiency
Muscle accumulation of Tc-99m diphosphonate in myophosphorylase deficiency and other disorders of muscle glycogenolysis/glycolysis.
glycogen phosphorylase deficiency
Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
glycogen phosphorylase deficiency
Muscle fatigue in McArdle's disease. Muscle fibre conduction velocity and surface EMG frequency spectrum during ischaemic exercise.
glycogen phosphorylase deficiency
Muscle fatigue in myophosphorylase deficiency: power spectral analysis of the electromyogram.
glycogen phosphorylase deficiency
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
glycogen phosphorylase deficiency
Muscle glycogen phosphorylase deficiency.
glycogen phosphorylase deficiency
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
glycogen phosphorylase deficiency
Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping.
glycogen phosphorylase deficiency
Muscle phosphorylase deficiency in childhood.
glycogen phosphorylase deficiency
MUSCLE PHOSPHORYLASE DEFICIENCY.
glycogen phosphorylase deficiency
Muscle Signaling in Exercise Intolerance: Insights from the McArdle Mouse Model.
glycogen phosphorylase deficiency
Muscle-type phosphorylase activity present in muscle cells cultured from three patients with myophosphorylase deficiency.
glycogen phosphorylase deficiency
Mutation analysis in myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
Myofibrillar activation failure in McArdle's disease.
glycogen phosphorylase deficiency
Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
glycogen phosphorylase deficiency
Myopathies due to enzyme deficiencies.
glycogen phosphorylase deficiency
Myophosphorylase deficiency (glycogen storage disease Type V) in a herd of Charolais cattle in New Zealand: confirmation by PCR-RFLP testing.
glycogen phosphorylase deficiency
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
glycogen phosphorylase deficiency
Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome.
glycogen phosphorylase deficiency
Myophosphorylase deficiency (McArdle's disease) in two interrelated families.
glycogen phosphorylase deficiency
Myophosphorylase deficiency (McArdle's disease): report of a family.
glycogen phosphorylase deficiency
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
glycogen phosphorylase deficiency
Myophosphorylase deficiency and limb-girdle muscular dystrophy in the same pedigree.
glycogen phosphorylase deficiency
Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain.
glycogen phosphorylase deficiency
Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle.
glycogen phosphorylase deficiency
Myophosphorylase deficiency impairs muscle oxidative metabolism.
glycogen phosphorylase deficiency
Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
glycogen phosphorylase deficiency
Myophosphorylase deficiency: the course of an unusual congenital myopathy.
glycogen phosphorylase deficiency
Myophosphorylase deficiency: two different molecular etiologies.
glycogen phosphorylase deficiency
No spontaneous second wind in muscle phosphofructokinase deficiency.
glycogen phosphorylase deficiency
Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
Oxidative stress and Nrf2 signaling in McArdle disease.
glycogen phosphorylase deficiency
Oxygen consumption is increased relative to work rate in patients with McArdle's disease.
glycogen phosphorylase deficiency
Pathophysiology of exercise performance in muscle disease.
glycogen phosphorylase deficiency
Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
Phenotype modulators in myophosphorylase deficiency.
glycogen phosphorylase deficiency
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
glycogen phosphorylase deficiency
Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
glycogen phosphorylase deficiency
Phosphorylase a deficiency in pseudohypoparathyroidism.
glycogen phosphorylase deficiency
Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart.
glycogen phosphorylase deficiency
Phosphorylation of McArdle phosphorylase induces activity.
glycogen phosphorylase deficiency
Physiologic assessment of phosphoglycerate mutase deficiency: incremental exercise test.
glycogen phosphorylase deficiency
Protein and amino acid metabolism in human muscle.
glycogen phosphorylase deficiency
Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency.
glycogen phosphorylase deficiency
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
glycogen phosphorylase deficiency
Reflex sympathetic activation during static exercise is severely impaired in patients with myophosphorylase deficiency.
glycogen phosphorylase deficiency
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
glycogen phosphorylase deficiency
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
glycogen phosphorylase deficiency
Study of myopathy in chronic alcoholics with neurological complication.
glycogen phosphorylase deficiency
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
glycogen phosphorylase deficiency
Successful pregnancy in a woman with glycogen storage disease type 6.
glycogen phosphorylase deficiency
Sudden infant death syndrome (SIDS) in a family with myophosphorylase deficiency.
glycogen phosphorylase deficiency
The effect of three test meals on exercise tolerance of an individual with McArdle's disease.
glycogen phosphorylase deficiency
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
glycogen phosphorylase deficiency
The metabolic causes of slow relaxation in fatigued human skeletal muscle.
glycogen phosphorylase deficiency
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
glycogen phosphorylase deficiency
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
glycogen phosphorylase deficiency
The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery.
glycogen phosphorylase deficiency
Three new mutations in patients with myophosphorylase deficiency (McArdle disease).
glycogen phosphorylase deficiency
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
glycogen phosphorylase deficiency
Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
glycogen phosphorylase deficiency
Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease.
glycogen phosphorylase deficiency
Two novel missense mutations (E654K, L396P) in Caucasian patients with myophosphorylase deficiency (McArdle's disease).
glycogen phosphorylase deficiency
Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
glycogen phosphorylase deficiency
Unforeseen Cardiac Involvement in McArdle's Disease.
glycogen phosphorylase deficiency
Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
glycogen phosphorylase deficiency
[Acute renal failure due to rhabdomyolysis in McArdle's disease following binge drinking with seizures]
glycogen phosphorylase deficiency
[Glycogenosis type V of adults: muscle phosphorylase deficiency]
glycogen phosphorylase deficiency
[Late diagnosis of a McArdle disease's case (type V glycogenosis).]
glycogen phosphorylase deficiency
[McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis]
glycogen phosphorylase deficiency
[McArdle disease: report of four brothers with myophosphorylase deficiency]
glycogen phosphorylase deficiency
[McArdle's disease--description based on three own observations (author's transl)]
glycogen phosphorylase deficiency
[McArdle's disease. Apropos of a case]
glycogen phosphorylase deficiency
[Muscle phosphorylase deficiency in childhood. A case report]
glycogen phosphorylase deficiency
[Myalgia during warming-up in a 12-year-old boy].
glycogen phosphorylase deficiency
[Myophosphorylase deficiency]
glycogen phosphorylase deficiency
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]
glycogen phosphorylase deficiency
[Rhabdomyolysis due to muscle enzyme deficiencies]
glycogen phosphorylase deficiency
[Study of metabolic myopathies using 1H NMR spectroscopy--analysis of muscle metabolites and muscle autolytic change]
Glycogen Storage Disease
A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity.
Glycogen Storage Disease
Acute renal failure due to rhabdomyolysis in a child with McArdle disease.
Glycogen Storage Disease
Anesthesia considerations in a patient with mcArdle disease: a case report.
Glycogen Storage Disease
Clinical and molecular characterization of McArdle's disease in Brazilian patients.
Glycogen Storage Disease
Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.
Glycogen Storage Disease
Differential glucose metabolism in mice and humans affected by McArdle disease.
Glycogen Storage Disease
Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Glycogen Storage Disease
Fatal infantile muscle phosphorylase deficiency.
Glycogen Storage Disease
Genetic deficiencies of the glycogen phosphorylase system.
Glycogen Storage Disease
Glycogen storage disease type VI: clinical course and molecular background.
Glycogen Storage Disease
Glycogen storage diseases of muscle.
Glycogen Storage Disease
Glycogenosis due to liver and muscle phosphorylase kinase deficiency.
Glycogen Storage Disease
High frequency of missense mutations in glycogen storage disease type VI.
Glycogen Storage Disease
Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI.
Glycogen Storage Disease
Immunological studies on glycogen storage diseases type 3 and V. Demonstration of the presence of an immunoreactive protein in one case of muscle phosphorylase deficiency.
Glycogen Storage Disease
Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Glycogen Storage Disease
Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.
Glycogen Storage Disease
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI.
Glycogen Storage Disease
McArdle disease: molecular genetic update.
Glycogen Storage Disease
McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
Glycogen Storage Disease
McArdle disease: what do neurologists need to know?
Glycogen Storage Disease
McArdle's disease presenting with asymmetric, late-onset arm weakness.
Glycogen Storage Disease
McArdle's disease: case report and review of the literature.
Glycogen Storage Disease
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Glycogen Storage Disease
Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
Glycogen Storage Disease
Mutation analysis in myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease
Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.
Glycogen Storage Disease
Myopathies due to enzyme deficiencies.
Glycogen Storage Disease
Novel variant in the PYGM gene causing late-onset limb-girdle myopathy, ptosis, and camptocormia.
Glycogen Storage Disease
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Glycogen Storage Disease
Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
Glycogen Storage Disease
Regional localization of loci on chromosome 14 using somatic cell hybrids.
Glycogen Storage Disease
Rhabdomyolysis in a patient with McArdle's disease.
Glycogen Storage Disease
Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Glycogen Storage Disease
Studies on a patient with in vivo evidence of type I glycogenosis and normal enzyme activities in vitro.
Glycogen Storage Disease
Successful pregnancy in a woman with glycogen storage disease type 6.
Glycogen Storage Disease
The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa.
Glycogen Storage Disease
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
Glycogen Storage Disease
The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.
Glycogen Storage Disease
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
Glycogen Storage Disease
[A case of acute renal failure secondary to late-onset McArdle's disease].
Glycogen Storage Disease
[A case of glycogen storage myopathy with acute heart failure]
Glycogen Storage Disease
[Anesthesia for cesarean section in a patient with McArdle disease and hereditary dilated cardiomyopathy]
Glycogen Storage Disease
[Glycogen storage disease associated with glycogen deposition in skeletal and heart muscles with low muscle phosphorylase activity]
Glycogen Storage Disease
[Glycogenosis type V of adults: muscle phosphorylase deficiency]
Glycogen Storage Disease
[Massive rhabdomyolysis revealing a McArdle disease.]
Glycogen Storage Disease
[One rare case report of acute renal insufficiency in rhabdomyolysis]
Glycogen Storage Disease
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Glycogen Storage Disease Type I
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
Glycogen Storage Disease Type II
Congenital and metabolic myopathies of childhood or adult onset.
Glycogen Storage Disease Type II
Glycogen storage diseases of muscle.
Glycogen Storage Disease Type II
Myopathies due to enzyme deficiencies.
Glycogen Storage Disease Type II
The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.
Glycogen Storage Disease Type III
Pathological characteristics of glycogen storage disease III in skeletal muscle.
Glycogen Storage Disease Type V
31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
Glycogen Storage Disease Type V
A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.
Glycogen Storage Disease Type V
A direct StyI polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) test for the myophosphorylase mutation in cattle.
Glycogen Storage Disease Type V
A High Creatine Kinase Concentration Might Be a Sign of McArdle Disease in Patient With Type 1 Diabetes.
Glycogen Storage Disease Type V
A homozygous missense mutation (A659D) in the myophosphorylase gene in a Spanish patient with McArdle's disease.
Glycogen Storage Disease Type V
A missense mutation T487N in the myophosphorylase gene in a Spanish patient with McArdle's disease.
Glycogen Storage Disease Type V
A missense mutation W797R in the myophosphorylase gene in a Spanish patient with McArdle's disease.
Glycogen Storage Disease Type V
A multi-parametric protocol to study exercise intolerance in McArdle's disease.
Glycogen Storage Disease Type V
A New Condition in McArdle Disease: Poor Bone Health-Benefits of an Active Lifestyle.
Glycogen Storage Disease Type V
A new mutation in the myophosphorylase gene (Asn684Tyr) in a Spanish patient with McArdle's disease.
Glycogen Storage Disease Type V
A new mutation in the regulatory domain of the myophosphorylase gene affecting protein dimer contact.
Glycogen Storage Disease Type V
A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease.
Glycogen Storage Disease Type V
A new stop codon mutation (Y52X) in the myophosphorylase gene in a Greek patient with McArdle's disease.
Glycogen Storage Disease Type V
A new variant of late-onset myophosphorylase deficiency.
Glycogen Storage Disease Type V
A nonsense mutation in the myophosphorylase gene in a Japanese family with McArdle's disease.
Glycogen Storage Disease Type V
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease.
Glycogen Storage Disease Type V
A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease.
Glycogen Storage Disease Type V
A novel nonsense mutation (R269X) in the myophosphorylase gene in a patient with McArdle disease.
Glycogen Storage Disease Type V
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
Glycogen Storage Disease Type V
A splice-site mutation causing ovine McArdle's disease.
Glycogen Storage Disease Type V
A thermodynamic function of glycogen in brain and muscle.
Glycogen Storage Disease Type V
A Transcriptomic Approach to Search for Novel Phenotypic Regulators in McArdle Disease.
Glycogen Storage Disease Type V
Absence of biochemical heterogeneity in McArdle's disease. A high resolution SDS-polyacrylamide gel electrophoresis study.
Glycogen Storage Disease Type V
Absence of exercise-induced MRI enhancement of skeletal muscle in McArdle's disease.
Glycogen Storage Disease Type V
Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
Glycogen Storage Disease Type V
Absence of p.R50X Pygm read-through in McArdle disease cellular models.
Glycogen Storage Disease Type V
Acid maltase deficiency and related myopathies.
Glycogen Storage Disease Type V
Acute renal failure in McArdle's disease.
Glycogen Storage Disease Type V
Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease: Expression and re-expression of glycogen phosphorylase.
Glycogen Storage Disease Type V
Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
Glycogen Storage Disease Type V
Aerobic conditioning: an effective therapy in McArdle's disease.
Glycogen Storage Disease Type V
An A-to-C substitution involving the translation initiation codon in a patient with myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
An elderly diabetic patient with McArdle disease and recurrent rhabdomyolysis: a potential association with late hypoinsulinemia?
Glycogen Storage Disease Type V
An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry.
Glycogen Storage Disease Type V
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
Glycogen Storage Disease Type V
Anesthesia considerations in a patient with mcArdle disease: a case report.
Glycogen Storage Disease Type V
Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase.
Glycogen Storage Disease Type V
ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
Glycogen Storage Disease Type V
Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon.
Glycogen Storage Disease Type V
Changes in force and intracellular metabolites during fatigue of human skeletal muscle.
Glycogen Storage Disease Type V
Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease.
Glycogen Storage Disease Type V
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Glycogen Storage Disease Type V
Clinical and molecular characterization of McArdle's disease in Brazilian patients.
Glycogen Storage Disease Type V
Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.
Glycogen Storage Disease Type V
Clinical spectrum of McArdle disease: three cases with unusual expression.
Glycogen Storage Disease Type V
Clinical utility gene card for McArdle disease.
Glycogen Storage Disease Type V
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Glycogen Storage Disease Type V
Cognitive impairment and McArdle disease: Is there a link?
Glycogen Storage Disease Type V
Congenital and metabolic myopathies of childhood or adult onset.
Glycogen Storage Disease Type V
Congenital myopathy due to phosphorylase deficiency.
Glycogen Storage Disease Type V
Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
Glycogen Storage Disease Type V
Depot-glucagon in the treatment of McArdle's disease.
Glycogen Storage Disease Type V
Diagnosis of McArdle's disease by molecular genetic analysis of blood.
Glycogen Storage Disease Type V
Differential glucose metabolism in mice and humans affected by McArdle disease.
Glycogen Storage Disease Type V
Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Glycogen Storage Disease Type V
Do carriers of PYGM mutations have symptoms of McArdle disease?
Glycogen Storage Disease Type V
Dominant inheritance of McArdle syndrome.
Glycogen Storage Disease Type V
Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
Glycogen Storage Disease Type V
Ectropion and epiphora in McArdle's syndrome.
Glycogen Storage Disease Type V
Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
Glycogen Storage Disease Type V
Electrophysiologic and histochemical observations in five patients with muscle phosphorylase deficiency (MPD).
Glycogen Storage Disease Type V
Exercise and Preexercise Nutrition as Treatment for McArdle Disease.
Glycogen Storage Disease Type V
Exercise induced fatigue: unfit or unwell?
Glycogen Storage Disease Type V
Exercise tolerance and daily life in McArdle's disease.
Glycogen Storage Disease Type V
Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Glycogen Storage Disease Type V
Expression of glycogen phosphorylase isoforms in cultured muscle from patients with McArdle's disease carrying the p.R771PfsX33 PYGM mutation.
Glycogen Storage Disease Type V
Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
Glycogen Storage Disease Type V
Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay.
Glycogen Storage Disease Type V
Fasting as a provocative test in neuromuscular diseases.
Glycogen Storage Disease Type V
Fat metabolism during exercise in patients with McArdle disease.
Glycogen Storage Disease Type V
Fatal infantile form of muscle phosphorylase deficiency.
Glycogen Storage Disease Type V
Fatal infantile muscle phosphorylase deficiency.
Glycogen Storage Disease Type V
Fatigue in human metabolic myopathy.
Glycogen Storage Disease Type V
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
Glycogen Storage Disease Type V
Genes and exercise intolerance: insights from McArdle disease.
Glycogen Storage Disease Type V
Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation.
Glycogen Storage Disease Type V
Genetic deficiencies of the glycogen phosphorylase system.
Glycogen Storage Disease Type V
Genetic test for myophosphorylase deficiency in Charolais cattle.
Glycogen Storage Disease Type V
Genotype modulators of clinical severity in McArdle disease.
Glycogen Storage Disease Type V
Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
Glycogen Storage Disease Type V
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
Glycogen Storage Disease Type V
Glycogen storage diseases of muscle.
Glycogen Storage Disease Type V
Glycogenosis type V (McArdle's disease) mimicking atypical myositis.
Glycogen Storage Disease Type V
High frequency of missense mutations in glycogen storage disease type VI.
Glycogen Storage Disease Type V
High-resolution melting facilitates mutation screening of PYGM in patients with McArdle disease.
Glycogen Storage Disease Type V
Higher oxidative stress in skeletal muscle of McArdle disease patients.
Glycogen Storage Disease Type V
Histochemical and biochemical studies in a patient with myophosphorylase deficiency.
Glycogen Storage Disease Type V
Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease.
Glycogen Storage Disease Type V
HyperCKemia as the only sign of McArdle's disease in a child.
Glycogen Storage Disease Type V
Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
Glycogen Storage Disease Type V
Immunological studies on glycogen storage diseases type 3 and V. Demonstration of the presence of an immunoreactive protein in one case of muscle phosphorylase deficiency.
Glycogen Storage Disease Type V
Impaired aerobic glycolysis in muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in 31P magnetic resonance spectroscopy.
Glycogen Storage Disease Type V
Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
Glycogen Storage Disease Type V
Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.
Glycogen Storage Disease Type V
Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
Increased PFK activity and GLUT4 protein content in McArdle's disease.
Glycogen Storage Disease Type V
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Glycogen Storage Disease Type V
Internal restriction sites: quality assurance aids in genotyping.
Glycogen Storage Disease Type V
Interrelationships between metabolism of glycogen phosphorylase and pyridoxal phosphate--implications in McArdle's disease.
Glycogen Storage Disease Type V
Investigating sodium valproate as a treatment for McArdle disease in sheep.
Glycogen Storage Disease Type V
Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease).
Glycogen Storage Disease Type V
Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Glycogen Storage Disease Type V
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
Glycogen Storage Disease Type V
Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.
Glycogen Storage Disease Type V
Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
Glycogen Storage Disease Type V
Lactate production in McArdle's disease.
Glycogen Storage Disease Type V
Late-onset Mcardle's disease with unusual electromyographic findings.
Glycogen Storage Disease Type V
Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.
Glycogen Storage Disease Type V
Low muscle levels of pyridoxine in McArdle's syndrome.
Glycogen Storage Disease Type V
Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.
Glycogen Storage Disease Type V
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
Glycogen Storage Disease Type V
Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.
Glycogen Storage Disease Type V
McArdle Disease and Exercise Physiology.
Glycogen Storage Disease Type V
McArdle disease: 2 case reports.
Glycogen Storage Disease Type V
McArdle disease: a case report and review.
Glycogen Storage Disease Type V
McArdle disease: a novel mutation in Jewish families from the Caucasus region.
Glycogen Storage Disease Type V
McArdle Disease: A Unique Study Model in Sports Medicine.
Glycogen Storage Disease Type V
McArdle disease: another systemic low-inflammation disorder?
Glycogen Storage Disease Type V
McArdle Disease: Clinical, Biochemical, Histological and Molecular Genetic Analysis of 60 Patients.
Glycogen Storage Disease Type V
McArdle disease: molecular genetic update.
Glycogen Storage Disease Type V
McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Glycogen Storage Disease Type V
McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
Glycogen Storage Disease Type V
McArdle disease: the mystery of reappearing phosphorylase activity in muscle culture--a fetal isoenzyme.
Glycogen Storage Disease Type V
McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.
Glycogen Storage Disease Type V
McArdle disease: what do neurologists need to know?
Glycogen Storage Disease Type V
McArdle's disease associated with homozygosity for the missense mutation Gly204Ser of the myophosphorylase gene in a Spanish patient.
Glycogen Storage Disease Type V
McArdle's disease diagnosed following statin-induced myositis.
Glycogen Storage Disease Type V
McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.
Glycogen Storage Disease Type V
McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote.
Glycogen Storage Disease Type V
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
Glycogen Storage Disease Type V
McArdle's disease presenting as treatment resistant polymyositis.
Glycogen Storage Disease Type V
McArdle's disease presenting as unexplained dyspnea in a young woman.
Glycogen Storage Disease Type V
McArdle's disease presenting with asymmetric, late-onset arm weakness.
Glycogen Storage Disease Type V
McArdle's disease resembling an inflammatory myopathy.
Glycogen Storage Disease Type V
McArdle's disease with late-onset symptoms: case report and review of the literature.
Glycogen Storage Disease Type V
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
Glycogen Storage Disease Type V
McArdle's disease with non-insulin-dependent diabetes mellitus: the beneficial effects of hyperglycemia and hyperinsulinemia for exercise intolerance.
Glycogen Storage Disease Type V
Mcardle's disease. A case report.
Glycogen Storage Disease Type V
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Glycogen Storage Disease Type V
McArdle's disease: a clinical review and case report.
Glycogen Storage Disease Type V
McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases.
Glycogen Storage Disease Type V
McArdle's disease: a rare frameshift mutation in exon 1 of the muscle glycogen phosphorylase gene.
Glycogen Storage Disease Type V
McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiency.
Glycogen Storage Disease Type V
McArdle's disease: case report and review of the literature.
Glycogen Storage Disease Type V
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Glycogen Storage Disease Type V
McArdle's disease: lack of muscle phosphorylase.
Glycogen Storage Disease Type V
McArdle's disease: molecular genetics and metabolic consequences of the phenotype.
Glycogen Storage Disease Type V
Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
Glycogen Storage Disease Type V
Metabolic control of cardiac output response to exercise in McArdle's disease.
Glycogen Storage Disease Type V
Minimally symptomatic mcardle disease, expanding the genotype-phenotype spectrum.
Glycogen Storage Disease Type V
Missense mutations have unexpected consequences: The McArdle disease paradigm.
Glycogen Storage Disease Type V
Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease.
Glycogen Storage Disease Type V
Molecular characterization of McArdle's disease in two large Finnish families.
Glycogen Storage Disease Type V
Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
Glycogen Storage Disease Type V
Molecular characterization of myophosphorylase deficiency in a group of patients from northern Italy.
Glycogen Storage Disease Type V
Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation.
Glycogen Storage Disease Type V
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
Molecular genetic study of myophosphorylase deficiency (McArdle's disease) in two Yemenite-Jewish families.
Glycogen Storage Disease Type V
Molecular heterogeneity in McArdle's disease.
Glycogen Storage Disease Type V
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
Glycogen Storage Disease Type V
Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
Glycogen Storage Disease Type V
Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.
Glycogen Storage Disease Type V
MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
Glycogen Storage Disease Type V
Muscle accumulation of Tc-99m diphosphonate in myophosphorylase deficiency and other disorders of muscle glycogenolysis/glycolysis.
Glycogen Storage Disease Type V
Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
Glycogen Storage Disease Type V
Muscle fatigue in McArdle's disease. Muscle fibre conduction velocity and surface EMG frequency spectrum during ischaemic exercise.
Glycogen Storage Disease Type V
Muscle fatigue in myophosphorylase deficiency: power spectral analysis of the electromyogram.
Glycogen Storage Disease Type V
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Glycogen Storage Disease Type V
Muscle glycogen phosphorylase deficiency.
Glycogen Storage Disease Type V
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Glycogen Storage Disease Type V
Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
Glycogen Storage Disease Type V
Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping.
Glycogen Storage Disease Type V
Muscle phosphorylase deficiency in childhood.
Glycogen Storage Disease Type V
MUSCLE PHOSPHORYLASE DEFICIENCY.
Glycogen Storage Disease Type V
Muscle Signaling in Exercise Intolerance: Insights from the McArdle Mouse Model.
Glycogen Storage Disease Type V
Muscle-type phosphorylase activity present in muscle cells cultured from three patients with myophosphorylase deficiency.
Glycogen Storage Disease Type V
Mutation analysis in myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
Myofibrillar activation failure in McArdle's disease.
Glycogen Storage Disease Type V
Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
Glycogen Storage Disease Type V
Myopathies due to enzyme deficiencies.
Glycogen Storage Disease Type V
Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.
Glycogen Storage Disease Type V
Myophosphorylase deficiency (glycogen storage disease Type V) in a herd of Charolais cattle in New Zealand: confirmation by PCR-RFLP testing.
Glycogen Storage Disease Type V
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
Glycogen Storage Disease Type V
Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome.
Glycogen Storage Disease Type V
Myophosphorylase deficiency (McArdle's disease) in two interrelated families.
Glycogen Storage Disease Type V
Myophosphorylase deficiency (McArdle's disease): report of a family.
Glycogen Storage Disease Type V
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Glycogen Storage Disease Type V
Myophosphorylase deficiency and limb-girdle muscular dystrophy in the same pedigree.
Glycogen Storage Disease Type V
Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain.
Glycogen Storage Disease Type V
Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle.
Glycogen Storage Disease Type V
Myophosphorylase deficiency impairs muscle oxidative metabolism.
Glycogen Storage Disease Type V
Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
Glycogen Storage Disease Type V
Myophosphorylase deficiency: the course of an unusual congenital myopathy.
Glycogen Storage Disease Type V
Myophosphorylase deficiency: two different molecular etiologies.
Glycogen Storage Disease Type V
Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro.
Glycogen Storage Disease Type V
No spontaneous second wind in muscle phosphofructokinase deficiency.
Glycogen Storage Disease Type V
Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
Novel variant in the PYGM gene causing late-onset limb-girdle myopathy, ptosis, and camptocormia.
Glycogen Storage Disease Type V
Oxidative stress and Nrf2 signaling in McArdle disease.
Glycogen Storage Disease Type V
Oxygen consumption is increased relative to work rate in patients with McArdle's disease.
Glycogen Storage Disease Type V
Pathologic quiz case: a man with exertion-induced cramps and myoglobinuria. McArdle disease (glycogenosis type V or myophosphorylase deficiency).
Glycogen Storage Disease Type V
Pathophysiology of exercise performance in muscle disease.
Glycogen Storage Disease Type V
Peripheral nerve and vasculature involvement in myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Glycogen Storage Disease Type V
Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
Glycogen Storage Disease Type V
Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Glycogen Storage Disease Type V
Phenotype modulators in myophosphorylase deficiency.
Glycogen Storage Disease Type V
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Glycogen Storage Disease Type V
Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders.
Glycogen Storage Disease Type V
Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart.
Glycogen Storage Disease Type V
Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease.
Glycogen Storage Disease Type V
Phosphorylation of McArdle phosphorylase induces activity.
Glycogen Storage Disease Type V
Physical training for McArdle disease.
Glycogen Storage Disease Type V
Physiologic assessment of phosphoglycerate mutase deficiency: incremental exercise test.
Glycogen Storage Disease Type V
PONM05 An unusual presentation of McArdle's disease.
Glycogen Storage Disease Type V
PRES leading to the diagnosis of McArdle disease.
Glycogen Storage Disease Type V
PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
Glycogen Storage Disease Type V
Recurrent Compartment Syndrome Leading to the Diagnosis of McArdle Disease: Case Report.
Glycogen Storage Disease Type V
Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency.
Glycogen Storage Disease Type V
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
Glycogen Storage Disease Type V
Reflex sympathetic activation during static exercise is severely impaired in patients with myophosphorylase deficiency.
Glycogen Storage Disease Type V
Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques.
Glycogen Storage Disease Type V
Results of an open label feasibility study of sodium valproate in people with McArdle disease.
Glycogen Storage Disease Type V
Rhabdomyolysis in a patient with McArdle's disease.
Glycogen Storage Disease Type V
Selective atrophy of type 1 muscle fibers in McArdle's disease.
Glycogen Storage Disease Type V
Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease.
Glycogen Storage Disease Type V
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Glycogen Storage Disease Type V
Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Glycogen Storage Disease Type V
Skeletal muscle disorders of glycogenolysis and glycolysis.
Glycogen Storage Disease Type V
Sodium valproate increases glycogen phosphorylase brain isoform: looking for a compensation mechanism in McArdle disease.
Glycogen Storage Disease Type V
Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
Glycogen Storage Disease Type V
Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease.
Glycogen Storage Disease Type V
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.
Glycogen Storage Disease Type V
Study of myopathy in chronic alcoholics with neurological complication.
Glycogen Storage Disease Type V
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Glycogen Storage Disease Type V
Sudden infant death syndrome (SIDS) in a family with myophosphorylase deficiency.
Glycogen Storage Disease Type V
Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease.
Glycogen Storage Disease Type V
The clinical diagnosis of McArdle's disease. Identification of another family with deficiency of muscle phosphorylase.
Glycogen Storage Disease Type V
The effect of three test meals on exercise tolerance of an individual with McArdle's disease.
Glycogen Storage Disease Type V
The metabolic causes of slow relaxation in fatigued human skeletal muscle.
Glycogen Storage Disease Type V
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
Glycogen Storage Disease Type V
The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery.
Glycogen Storage Disease Type V
The role of lipid peroxidation in McArdle's disease: applications for treatment of other myopathies.
Glycogen Storage Disease Type V
Therapeutic options in other metabolic myopathies.
Glycogen Storage Disease Type V
Three new mutations in patients with myophosphorylase deficiency (McArdle disease).
Glycogen Storage Disease Type V
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Glycogen Storage Disease Type V
Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
Glycogen Storage Disease Type V
Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
Glycogen Storage Disease Type V
Two homozygous mutations (R193W and 794/795 delAA) in the myophosphorylase gene in a patient with McArdle's disease.
Glycogen Storage Disease Type V
Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease.
Glycogen Storage Disease Type V
Two novel missense mutations (E654K, L396P) in Caucasian patients with myophosphorylase deficiency (McArdle's disease).
Glycogen Storage Disease Type V
Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
Glycogen Storage Disease Type V
Two novel mutations in the myophosphorylase gene in a patient with McArdle disease.
Glycogen Storage Disease Type V
Unforeseen Cardiac Involvement in McArdle's Disease.
Glycogen Storage Disease Type V
Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene.
Glycogen Storage Disease Type V
Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
Glycogen Storage Disease Type V
Wave of renal impairment.
Glycogen Storage Disease Type V
Xanthine oxidase pathway and muscle damage. Insights from McArdle disease.
Glycogen Storage Disease Type V
[Acute renal failure due to rhabdomyolysis in McArdle's disease following binge drinking with seizures]
Glycogen Storage Disease Type V
[Anesthesia in a Patient with McArdle Disease].
Glycogen Storage Disease Type V
[Glycogenosis type V of adults: muscle phosphorylase deficiency]
Glycogen Storage Disease Type V
[Late diagnosis of a McArdle disease's case (type V glycogenosis).]
Glycogen Storage Disease Type V
[Massive rhabdomyolysis revealing a McArdle disease.]
Glycogen Storage Disease Type V
[McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis]
Glycogen Storage Disease Type V
[McArdle disease: differential diagnosis of the increase in creatine kinase induced by the exercise test]
Glycogen Storage Disease Type V
[McArdle disease: report of four brothers with myophosphorylase deficiency]
Glycogen Storage Disease Type V
[MCARDLE'S DISEASE AND PHYSICAL ACTIVITY - A MIXED BLESSING].
Glycogen Storage Disease Type V
[McArdle's disease in a 14-year-old girl with fatigability and raised muscle enzymes]
Glycogen Storage Disease Type V
[McArdle's disease in adults: clinical and genetic study]
Glycogen Storage Disease Type V
[McArdle's disease--description based on three own observations (author's transl)]
Glycogen Storage Disease Type V
[McArdle's disease. Apropos of a case]
Glycogen Storage Disease Type V
[Metabolic intolerance to exercise]
Glycogen Storage Disease Type V
[Motor nerve conduction study in McArdle disease: case report]
Glycogen Storage Disease Type V
[Muscle phosphorylase deficiency in childhood. A case report]
Glycogen Storage Disease Type V
[Myalgia during warming-up in a 12-year-old boy].
Glycogen Storage Disease Type V
[Myophosphorylase deficiency]
Glycogen Storage Disease Type V
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]
Glycogen Storage Disease Type V
[Private mutations in the myophosphorylase gene: the first case in a PATIENT of Latin American descent.]
Glycogen Storage Disease Type V
[Rhabdomyolysis due to muscle enzyme deficiencies]
Glycogen Storage Disease Type V
[Study of metabolic myopathies using 1H NMR spectroscopy--analysis of muscle metabolites and muscle autolytic change]
Glycogen Storage Disease Type V
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Glycogen Storage Disease Type VI
Glycogen storage disease type VI: clinical course and molecular background.
Glycogen Storage Disease Type VI
Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI.
Glycogen Storage Disease Type VI
Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI.
Glycogen Storage Disease Type VI
Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.
Glycogen Storage Disease Type VI
Regional localization of loci on chromosome 14 using somatic cell hybrids.
Glycogen Storage Disease Type VI
Successful pregnancy in a woman with glycogen storage disease type 6.
Glycogen Storage Disease Type VI
The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.
Glycogen Storage Disease Type VI
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
Glycogen Storage Disease Type VII
Free Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS.
Glycogen Storage Disease Type VII
Magnetic resonance imaging of muscle injury and atrophy in glycolytic myopathies.
Glycogen Storage Disease Type VII
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms.
Glycogen Storage Disease Type VII
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Glycosuria
Increase in liver protein phosphatase-1 in spontaneously diabetic Chinese hamsters.
Gout
Can hyperuricemia predict glycogen storage disease (McArdle's disease) in rheumatology practice? (Myogenic hyperuricemia).
Heart Diseases
Enzyme pattern in endomyocardial biopsies from patients with chronic heart diseases.
Heart Diseases
Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart.
Heart Diseases
[Biochemical markers in the diagnosis of acute coronary syndrome]
Hematologic Neoplasms
Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies.
Hepatomegaly
Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL).
Hepatomegaly
The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14.
Hydatidiform Mole
Glycogen metabolism in vesicles of hydatidiform mole in vitro.
Hyperandrogenism
A nontargeted study of muscle proteome in severely obese women with androgen excess compared with severely obese men and nonhyperandrogenic women.
Hyperglycemia
Advances in glycogen phosphorylase inhibitor design.
Hyperglycemia
Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.
Hyperglycemia
Altered control of carbohydrate metabolism in endotoxemia.
Hyperglycemia
Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
Hyperglycemia
Discovery of a Genetic Metabolic Cause for Mauriac Syndrome in Type 1 Diabetes.
Hyperglycemia
Effects of acute variation of fetal glycemia on glycogen storage and on glycogen synthase and phosphorylase activities in the liver of the rat fetus.
Hyperglycemia
Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
Hyperglycemia
FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. I. Taxonomy, fermentation, isolation and biological activities.
Hyperglycemia
Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
Hyperglycemia
Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in rats following subchronic exposure to malathion.
Hyperglycemia
Inability of hyperglycemia to counter the ability of glucagon to increase net glucose output and activate glycogen phosphorylase in the perfused rat liver.
Hyperglycemia
Liver-specific iNOS expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.
Hyperglycemia
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
Hyperglycemia
Mode of action of dopamine in inducing hyperglycemia in the fresh water edible crab, Oziothelphusa senex senex.
Hyperglycemia
Novel therapeutics based on inhibiting the interaction of glycogen phosphorylase and G(L)-subunit of glycogen-associated protein phosphatase 1: WO2009127723.
Hyperglycemia
Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
Hyperglycemia
Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: Comparison of chrysin and flavopiridol.
Hyperglycemia
Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors.
Hyperglycemia
Synthesis of 5-halogenated 1,2,3-triazoles under stoichiometric Cu(I)-mediated azide-alkyne cycloaddition (CuAAC or 'Click Chemistry').
Hyperinsulinism
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
Hyperlipidemias
Tests of potential adipokinetic hormone precursor related peptide (APRP) functions: lack of responses.
Hypersensitivity
A hypersensitivity of glycogen phosphorylase activation in hearts of diabetic rats.
Hypersensitivity
Phosphorylase activation hypersensitivity in hearts of diabetic rats.
Hyperthyroidism
Effects of perhexiline on myocardial phosphorylase activity, myocardial catecholamine content and heart rate.
Hyperthyroidism
Glycogen and glycogen enzymes in the liver and striated muscle of rats under altered thyroid states.
Hyperthyroidism
Hyperthyroidism impairs the activation of glycogen phosphorylase by epinephrine in rat hepatocytes.
Hyperthyroidism
Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart.
Hyperthyroidism
The effect of dibutyryl cyclic AMP on cardiac phosphorylase a activity in euthyroid and hyperthyroid hearts.
Hyperthyroidism
The effect of noradrenaline and tyramine on cardiac contractility, cyclic AMP, and phosphorylase a in normal and hyperthyroid rats.
Hyperthyroidism
Triiodo-L-thyronine stimulates glycogen synthesis in rat hepatocyte cultures.
Hypoglycemia
A fall in portal vein insulin does not cause the alpha-cell response to mild, non-insulin-induced hypoglycemia in conscious dogs.
Hypoglycemia
Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.
Hypoglycemia
Altered Plasticity of Glycogen Phosphorylase in Forebrain Gliosomes Obtained from Insulinoma Patients.
Hypoglycemia
Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide).
Hypoglycemia
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Hypoglycemia
Counterregulation of hypoglycemia. Skeletal muscle glycogen metabolism during three hours of physiological hyperinsulinemia in humans.
Hypoglycemia
Glycogenic effect of an alkali soluble fraction from sepia shell.
Hypoglycemia
Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Hypoglycemia
Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia.
Hypoglycemia
Liver glycogen metabolism during short-term insulin-induced hypoglycemia in fed rats.
Hypoglycemia
Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input.
Hypoglycemia
Postnatal profiles of glycogenolysis and gluconeogenesis are modified in rat pups by maternal dietary glucose restriction.
Hypokalemic Periodic Paralysis
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Hypothyroidism
Coupled diminished energy turnover and phosphorylase a formation in contracting hypothyroid rat muscle.
Hypothyroidism
Glycogen and glycogen enzymes in the liver and striated muscle of rats under altered thyroid states.
Hypothyroidism
Phosphorylase a formation in protein-glycogen particles isolated from fast-twitch muscle of euthyroid and hypothyroid rats.
Infections
Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism.
Infections
Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.
Insulin Resistance
Chebulagic acid attenuates HFD/Streptozotocin induced impaired glucose metabolism and insulin resistance via up regulations of PPAR ? and GLUT 4 in type 2 diabetic rats.
Insulin Resistance
Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.
Insulin Resistance
Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
Insulin Resistance
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance.
Insulin Resistance
Insulin resistance limits glucose utilization and exercise tolerance in myophosphorylase deficiency and NIDDM.
Insulin Resistance
Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.
Insulin Resistance
Intermittent fasting reduces body fat but exacerbates hepatic insulin resistance in young rats regardless of high protein and fat diets.
Insulin Resistance
Mitigating Perspectives of Asiatic acid in the Renal derangements of Streptozotocin-Nicotinamide induced Diabetic Rats.
Insulin Resistance
Pentacyclic triterpenoids from spikes of Prunella vulgaris L. inhibit glycogen phosphorylase and improve insulin sensitivity in 3T3-L1 adipocytes.
Insulin Resistance
The effect of alcohol on blood glucose in Type 1 diabetes--metabolic modelling and integration in a decision support system.
Insulinoma
Altered Plasticity of Glycogen Phosphorylase in Forebrain Gliosomes Obtained from Insulinoma Patients.
Insulinoma
Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
Ischemic Stroke
New biomarker for acute ischaemic stroke: plasma glycogen phosphorylase isoenzyme BB.
Lacrimal Apparatus Diseases
Ectropion and epiphora in McArdle's syndrome.
Leukemia
Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia.
Leukemia
Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.
Leukemia
Response variability in Attention-Deficit Hyperactivity Disorder: A neuronal and glial energetics hypothesis.
Leukemia
[Enzyme histochemical studies of malignant tumors in childhood. 2. Enzyme histochemical study on beta-glucuronidase and amylophosphorylase in acute leukemia]
Liver Cirrhosis
Restoration of the glycogen-forming function of hepatocytes in rats with liver cirrhosis is facilitated by a high-carbohydrate diet.
Liver Cirrhosis, Biliary
Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase.
Liver Cirrhosis, Biliary
M4 and M9 autoantigens in primary biliary cirrhosis--a negative study.
Liver Diseases
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Liver Diseases
Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.
Liver Failure
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Liver Neoplasms
Carcinofetal alterations in glycogen phosphorylase isozymes in rat hepatomas.
Liver Neoplasms, Experimental
Glycogen phosphorylase isoenzymes from hepatoma 3924A and from a non-tumorigenic liver cell line. Comparison with the liver and brain enzymes.
Liver Neoplasms, Experimental
Purification and characterization of the Novikoff hepatoma glycogen phosphorylase and its relations to a fetal form.
Lung Neoplasms
Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Lung Neoplasms
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Metabolism, Inborn Errors
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Mitochondrial Myopathies
Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.
Mitochondrial Myopathies
Pathophysiology of exercise performance in muscle disease.
Mitochondrial Myopathies
Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
Mitochondrial Myopathies
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Multiple Endocrine Neoplasia
The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
Multiple Endocrine Neoplasia Type 1
The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
Multiple Myeloma
Abnormal platelet glycogen metabolism in multiple myeloma patients.
Muscle Cramp
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Muscle Cramp
Acid maltase deficiency and related myopathies.
Muscle Cramp
Aerobic conditioning: an effective therapy in McArdle's disease.
Muscle Cramp
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Muscle Cramp
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
Muscle Cramp
McArdle's disease in childhood: report of a new case.
Muscle Cramp
McArdle's disease presenting with asymmetric, late-onset arm weakness.
Muscle Cramp
McArdle's disease: case report and review of the literature.
Muscle Cramp
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Muscle Cramp
Muscle phosphorylase deficiency in childhood.
Muscle Cramp
Pathologic quiz case: a man with exertion-induced cramps and myoglobinuria. McArdle disease (glycogenosis type V or myophosphorylase deficiency).
Muscle Cramp
Phenotype modulators in myophosphorylase deficiency.
Muscle Cramp
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
Muscle Weakness
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Muscle Weakness
Myopathies due to enzyme deficiencies.
Muscular Atrophy
Effect of denervation on the expression of glycogen phosphorylase in mouse skeletal muscle.
Muscular Atrophy
Reduced glycogen phosphorylase activity in denervated hindlimb muscles of rat is related to muscle atrophy and fibre type.
Muscular Diseases
A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis.
Muscular Diseases
A metabolic myopathy due to absence of muscle phosphorylase.
Muscular Diseases
A multi-parametric protocol to study exercise intolerance in McArdle's disease.
Muscular Diseases
A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
Muscular Diseases
A splice-site mutation causing ovine McArdle's disease.
Muscular Diseases
Acid maltase deficiency and related myopathies.
Muscular Diseases
Acute renal failure in McArdle's disease.
Muscular Diseases
An elderly diabetic patient with McArdle disease and recurrent rhabdomyolysis: a potential association with late hypoinsulinemia?
Muscular Diseases
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
Muscular Diseases
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Muscular Diseases
Clinical spectrum of McArdle disease: three cases with unusual expression.
Muscular Diseases
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Muscular Diseases
Congenital and metabolic myopathies of childhood or adult onset.
Muscular Diseases
Congenital myopathy due to phosphorylase deficiency.
Muscular Diseases
Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.
Muscular Diseases
McArdle Disease and Exercise Physiology.
Muscular Diseases
McArdle disease: a case report and review.
Muscular Diseases
McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Muscular Diseases
McArdle disease: what do neurologists need to know?
Muscular Diseases
McArdle's disease presenting with asymmetric, late-onset arm weakness.
Muscular Diseases
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Muscular Diseases
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
Muscular Diseases
Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
Muscular Diseases
Monocarboxylate transporters and mitochondrial creatine kinase protein content in McArdle disease.
Muscular Diseases
MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
Muscular Diseases
Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Muscular Diseases
Myopathies due to enzyme deficiencies.
Muscular Diseases
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy.
Muscular Diseases
Myophosphorylase deficiency: the course of an unusual congenital myopathy.
Muscular Diseases
Oxidative stress and Nrf2 signaling in McArdle disease.
Muscular Diseases
Physical training for McArdle disease.
Muscular Diseases
Selective atrophy of type 1 muscle fibers in McArdle's disease.
Muscular Diseases
Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease.
Muscular Diseases
The effect of three test meals on exercise tolerance of an individual with McArdle's disease.
Muscular Diseases
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
Muscular Diseases
Translational Medicine: Exercise Physiology Applied to Metabolic Myopathies.
Muscular Diseases
Unforeseen Cardiac Involvement in McArdle's Disease.
Muscular Diseases
[Late diagnosis of a McArdle disease's case (type V glycogenosis).]
Muscular Diseases
[McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis]
Muscular Diseases
[MCARDLE'S DISEASE AND PHYSICAL ACTIVITY - A MIXED BLESSING].
Muscular Diseases
[McArdle's disease in adults: clinical and genetic study]
Muscular Diseases
[Motor nerve conduction study in McArdle disease: case report]
Muscular Diseases
[Myalgia during warming-up in a 12-year-old boy].
Muscular Diseases
[On progressive myopathy with muscle phosphorylase deficiency and giant mitochondria]
Muscular Diseases
[Private mutations in the myophosphorylase gene: the first case in a PATIENT of Latin American descent.]
Muscular Diseases
[Rhabdomyolysis due to muscle enzyme deficiencies]
Muscular Diseases
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Muscular Dystrophies
[STUDIES ON MUSCLE PHOSPHORYLASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY.]
Muscular Dystrophies, Limb-Girdle
Myophosphorylase deficiency and limb-girdle muscular dystrophy in the same pedigree.
Myalgia
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Myalgia
Acid maltase deficiency and related myopathies.
Myalgia
McArdle's disease presenting with asymmetric, late-onset arm weakness.
Myalgia
McArdle's disease: case report and review of the literature.
Myalgia
Muscle pain in myophosphorylase deficiency (McArdle's disease): the role of gender, genotype, and pain-related coping.
Myalgia
[McArdle disease: differential diagnosis of the increase in creatine kinase induced by the exercise test]
Myocardial Infarction
Design, Synthesis, and Use of Novel Photoaffinity Probes in Measuring the Serum Concentration of Glycogen Phosphorylase.
Myocardial Infarction
Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.
Myocardial Infarction
Glycogen phosphorylase BB in myocardial infarction.
Myocardial Infarction
Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.
Myocardial Infarction
Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis.
Myocardial Infarction
Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting.
Myocardial Infarction
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
Myocardial Infarction
Isoenzyme BB of glycogen phosphorylase b and myocardial infarction.
Myocardial Infarction
Serum glycogen phosphorylase b: a new enzyme test for myocardial infarction.
Myocardial Infarction
The assay of glycogen phosphorylase in human blood serum and its application to the diagnosis of myocardial infarction.
Myocardial Infarction
[Base activity of glycogen phosphorylase b in human serum. Study of reference and discrimination values]
Myocardial Infarction
[Determination of glycogen phosphorylase B--a contribution to the enzymatic diagnosis of acute myocardial infarct]
Myocardial Infarction
[Dynamics of blood glycogen phosphorylase during acute myocardial infarct]
Myocardial Infarction
[Effect of physical loading on serum enzyme activity in post-myocardial infarct patients]
Myocardial Infarction
[Glycogen phosphorylase activity in acute myocardial infarction]
Myocardial Infarction
[Glycogen phosphorylase activity in infarct-affected and nonaffected parts of the human myocardium after death]
Myocardial Infarction
[Glycogen phosphorylase b: a new serum enzyme test for myocardial infarct]
Myocardial Infarction
[Immunoinhibition test for human glycogen phosphorylase BB in the diagnosis of acute myocardial infarct]
Myocardial Infarction
[Relationship between glycogen phosphorylase BB and cardiac ischemic area or infarction area in experimental acute myocardial infarction.]
Myocardial Infarction
[Separation of glycogen phosphorylase isoenzymes using electrophoresis in acetate cellulose]
Myocardial Infarction
[The determination of the glycogen phosphorylase activity in blood serum]
Myocardial Ischemia
Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
Myocardial Ischemia
Glycogen phosphorylase isoenzyme BB plasma kinetics is not related to myocardial ischemia induced by exercise stress echo test.
Myocardial Ischemia
On the mechanism of action of the antianginal drug nonachlazine on ischemic myocardium.
Myocardial Ischemia
[Base activity of glycogen phosphorylase b in human serum. Study of reference and discrimination values]
Myocarditis
Enzyme pattern and lipid peroxides in endomyocardial biopsies from patients with cardiomyopathy and myocarditis.
Myoglobinuria
A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
Myoglobinuria
Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
Myoglobinuria
Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease.
Myoglobinuria
Dominant inheritance of McArdle syndrome.
Myoglobinuria
Glycogen storage diseases of muscle.
Myoglobinuria
Laboratory diagnosis of the neuromuscular glycogen storage diseases.
Myoglobinuria
McArdle's disease presenting with asymmetric, late-onset arm weakness.
Myoglobinuria
McArdle's disease: case report and review of the literature.
Myoglobinuria
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
Myoglobinuria
Muscle phosphorylase deficiency in childhood.
Myoglobinuria
Myoglobinuria and skeletal muscle phosphorylase deficiency: report of a case of McArdle's disease.
Myoglobinuria
Myophosphorylase deficiency (glycogenosis type V; McArdle disease).
Myoglobinuria
Myophosphorylase deficiency associated with a defect in complex I of the mitochondrial respiratory chain.
Myoglobinuria
Myophosphorylase deficiency: an unusually severe form with myoglobinuria.
Myoglobinuria
Pathologic quiz case: a man with exertion-induced cramps and myoglobinuria. McArdle disease (glycogenosis type V or myophosphorylase deficiency).
Myoglobinuria
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Myoglobinuria
Phenotype modulators in myophosphorylase deficiency.
Myoglobinuria
Recurrent myoglobinuria due to muscle carnitine palmityl transferase deficiency.
Myoglobinuria
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).
Myoglobinuria
[Clinical demonstrations of hereditary disorders of metabolism]
Myoma
[Properties of glycogen phosphorylase B from human uterine myoma]
Myopathies, Nemaline
Congenital and metabolic myopathies of childhood or adult onset.
Myositis
Muscle biopsy features in critical ill patients with 2009 influenza A (H1N1) virus infection.
Myotonia Congenita
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Neoplasm Metastasis
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
Neoplasm Metastasis
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Neoplasms
Activity of enzymes related to carbohydrate metabolism in the HT 29 colon adenocarcinoma cell line and tumor.
Neoplasms
Assignment of the human FAU gene to a subregion of chromosome 11q13.
Neoplasms
Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.
Neoplasms
Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers.
Neoplasms
Does dexmedetomidine have a cardiac protective effect during non-cardiac surgery? A randomised controlled trial.
Neoplasms
Effect of alkylating agents on glycogen phosphorylase activity of ascites tumor cells.
Neoplasms
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
Neoplasms
Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
Neoplasms
Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.
Neoplasms
Glycogen phosphorylase activities of tumors, regenerating rat liver and suckling rat liver.
Neoplasms
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis.
Neoplasms
Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Neoplasms
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Neoplasms
Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats.
Neoplasms
Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells.
Neoplasms
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Neoplasms
Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression.
Neoplasms
Isozymes of glycogen phosphorylase in human cartilage and cartilage tumors.
Neoplasms
Linking glycogen and senescence in cancer cells.
Neoplasms
Metabolic phenotype of bladder cancer.
Neoplasms
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
Neoplasms
Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Neoplasms
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Neoplasms
Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Neoplasms
Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation.
Neoplasms
Pharmacology and clinical status of capecitabine.
Neoplasms
Phosphorylase: a new isozyme in rat hepatic tumors and fetal liver.
Neoplasms
PYGB facilitates cell proliferation and invasion in non-small cell lung cancer through activating Wnt/?-catenin signaling.
Neoplasms
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Neoplasms
PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
Neoplasms
Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
Neoplasms
Synthesis, Kinetic and Conformational Studies of 2-Substituted-5-(?-d-glucopyranosyl)-pyrimidin-4-ones as Potential Inhibitors of Glycogen Phosphorylase.
Neoplasms
Targeting glycogen metabolism in bladder cancer.
Neoplasms
The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma.
Neoplasms
The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
Neoplasms
Tumor hypoglycemia induced in nude mice by a heterotransplantable human ovarian carcinoma line (OCL-1).
Neoplasms
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
Neoplasms
[Biochemical investigations of cancer cachexia. II. Depletion of glycogenolysis and stimulation of gluconeogenesis in Walker carcinoma 256 bearing rats (author's transl)]
Neoplasms
[Enzyme histochemical studies of malignant tumors in childhood. 2. Enzyme histochemical study on beta-glucuronidase and amylophosphorylase in acute leukemia]
Neoplasms
[Histochemical studies on intracellular glycogen metabolism in AH 13 ascites tumor cells. 2. AH 13 cell cycle and intracellular reaction of glycogen, phosphorylase and UDPG-glycogen glucosyltransferase]
Non-alcoholic Fatty Liver Disease
The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
Obesity
Obesity and the regulation of phosphofructokinase in heart: an apparent insensitivity to adrenergic activation in mature-age genetically obese rats.
Osteoarthritis
Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects.
Osteoarthritis, Knee
Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects.
Ovarian Neoplasms
Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/?-catenin signaling and is regulated by miR-133a-3p.
Pancreatic Neoplasms
Inhibition of Glycogen Phosphorylation Induces Changes in Cellular Proteome and Signaling Pathways in MIA Pancreatic Cancer Cells.
Pancreatic Neoplasms
The intracellular mechanism of insulin resistance in pancreatic cancer patients.
Paralysis
Internal restriction sites: quality assurance aids in genotyping.
Paralysis
Single-fiber electromyography in neuromuscular disorders: correlation of muscle histochemistry, single-fiber electromyography, and clinical findings.
Paralysis, Hyperkalemic Periodic
Internal restriction sites: quality assurance aids in genotyping.
Pheochromocytoma
Activation of glycogen phosphorylase in rat pheochromocytoma PC12 cells and isolated hepatocytes by organophosphates.
Pheochromocytoma
Calcium-dependent activation of glycogen phosphorylase in rat pheochromocytoma PC12 cells by nerve growth factor.
phosphorylase kinase deficiency
Adult-onset exercise intolerance due to phosphorylase b kinase deficiency.
phosphorylase kinase deficiency
Characterization of the phosphorylase b to a converting activity in skeletal muscle extracts of mice with the phosphorylase b kinase deficiency mutation.
phosphorylase kinase deficiency
Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency.
phosphorylase kinase deficiency
Fueling around with glycogen: the implications of muscle phosphorylase b kinase deficiency.
phosphorylase kinase deficiency
Genetic deficiencies of the glycogen phosphorylase system.
phosphorylase kinase deficiency
Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.
phosphorylase kinase deficiency
Glycogenosis due to liver and muscle phosphorylase kinase deficiency.
phosphorylase kinase deficiency
Muscle phosphorylase b kinase deficiency revisited.
phosphorylase kinase deficiency
Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
phosphorylase kinase deficiency
Skeletal muscle phosphorylase kinase deficiency: detection of a protein lacking any activity in ICR-IAn mice.
phosphorylase kinase deficiency
The molecular basis of skeletal muscle phosphorylase kinase deficiency.
phosphorylase kinase deficiency
The phosphorylase kinase activity of hearts from phosphorylase kinase-deficient mice.
phosphorylase kinase deficiency
Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI.
phosphorylase kinase deficiency
X-linked dominant inheritance of partial phosphorylase kinase deficiency in mice.
Porphyrias, Hepatic
Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species.
Pre-Eclampsia
Altered Maternal Plasma Glycogen Phosphorylase Isoenzyme BB as a Biomarker for Preeclampsia and Small for Gestational Age.
Pre-Eclampsia
Assessment of glycogen phosphorylase isoenzyme BB as a biomarker for pre-eclampsia and small for gestational age.
Pre-Eclampsia
cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia.
Pre-Eclampsia
Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.
Pre-Eclampsia
Markers of maternal cardiac dysfunction in pre-eclampsia and superimposed pre-eclampsia.
Pre-Eclampsia
PP054. Elevated maternal plasma glycogen phosphorylase isoenzyme BB as time of disease biomarker of pre-eclampsia and small-for-gestational-age.
Prostatic Neoplasms
Targeting glycogen metabolism in bladder cancer.
Pseudohypoparathyroidism
Phosphorylase a deficiency in pseudohypoparathyroidism.
Pulmonary Disease, Chronic Obstructive
Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease.
Renal Insufficiency
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
Reperfusion Injury
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
Respiratory Insufficiency
Fatal arthrogryposis with respiratory insufficiency: a possible case of muscle phosphorylase b-kinase deficiency.
Retinoblastoma
Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line.
Retinoblastoma
Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells.
Rhabdomyolysis
Acute renal failure in McArdle's disease.
Rhabdomyolysis
Aerobic conditioning: an effective therapy in McArdle's disease.
Rhabdomyolysis
False negative histochemical reaction for myophosphorylase activity in fulminant sepsis due to methicillin resistant Staphylococcus aureus.
Rhabdomyolysis
Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle.
Rhabdomyolysis
Natural history of potassium-deficiency myopathy in the dog: role of adrenocorticosteroid in rhabdomyolysis.
Rhabdomyolysis
Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
Rhabdomyolysis
Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Rhabdomyolysis
[Rhabdomyolysis due to muscle enzyme deficiencies]
Rhabdomyosarcoma
An evaluation of enzyme histochemistry in the diagnosis of childhood rhabdomyosarcoma.
Sarcoidosis, Pulmonary
[Successful treatment with infliximab of a patient with refractory sarcoidosis]
Sarcoma, Myeloid
Enzymes of glycogen metabolism in white blood cells. 3. Heterogeneity of glycogen phosphorylase from rat chloroma.
Sarcoma, Myeloid
Enzymes of glycogen metabolism in white blood cells. II. Activation and inactivation of glycogen phosphorylase of rat chloroma.
Seizures
Changes in glycogen phosphorylase activity and glycogen levels of mouse cerebral cortex during convulsions induced by homocysteine.
Seizures
Changes of cyclic AMP and phosphorylase a in mouse cerebral cortex during seizures induced by 3-mercaptopropionic acid.
Seizures
Convulsions as the etiology of lactic acidosis in acute diazinon toxicity in rats.
Seizures
Glycogen phosphorylase activity in the cerebral cortex of rats during development: effect of homocysteine-induced seizures.
Seizures
McArdle's disease presenting as recurrent cryptogenic renal failure due to occult seizures.
Sepsis
False negative histochemical reaction for myophosphorylase activity in fulminant sepsis due to methicillin resistant Staphylococcus aureus.
Sepsis
Perturbation of transmembrane signaling mechanisms in acute and chronic endotoxemia.
Sepsis
Protein phosphorylation in isolated hepatocytes of septic and endotoxemic rats.
Sepsis
Rat liver free cytosolic Ca2+ and glycogen phosphorylase in endotoxicosis and sepsis.
Sepsis
The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury.
Shock, Septic
Liver glycogen metabolism in endotoxin shock. II. Endotoxin administration increases glycogen phosphorylase activities in dog livers.
Skin Abnormalities
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Sleep Deprivation
Sleep deprivation modulates brain mRNAs encoding genes of glycogen metabolism.
Starvation
Activity of enzymes regulating glycogen metabolism in perfused muscle-cuticle sections of Ascaris suum (Nematoda).
Starvation
Activity of glycogen metabolizing enzymes in glucose deprived HT 29 adenocarcinoma cell-line.
Starvation
Carbohydrate metabolism during starvation in the silkworm Bombyx mori.
Starvation
Developmental changes in the response of larval Manduca sexta fat body glycogen phosphorylase to starvation, stress and octopamine.
Starvation
Effect of starvation on glycogen and glucose metabolism in different areas of the rat brain.
Starvation
Effects of starvation on the carbohydrate metabolism in Harmonia axyridis (Pallas).
Starvation
Enzyme Sets of Glycolysis, Gluconeogenesis, and Oxidative Pentose Phosphate Pathway Are Not Complete in Nongreen Highly Purified Amyloplasts of Sycamore (Acer pseudoplatanus L.) Cell Suspension Cultures.
Starvation
Hormonal regulation of fat body glycogen phosphorylase activity in larval Manduca sexta during starvation.
Starvation
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Starvation
Physiological role of skeletal muscle glycogen in starved mice.
Starvation
Sequencing and characterization of glycogen synthase and glycogen phosphorylase genes from Spodoptera exigua and analysis of their function in starvation and excessive sugar intake.
Starvation
Significance of the increase in glucose 6-phosphatase activity in skeletal muscle cells of the mouse by starvation.
Starvation
The behavior of muscle phosphorylase as a reservoir for vitamin B6 in the rat.
Starvation
The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice.
Starvation
The putative AKH receptor of the tobacco hornworm, Manduca sexta, and its expression.
Status Epilepticus
Acute and chronic changes in glycogen phosphorylase in hippocampus and entorhinal cortex after status epilepticus in the adult male rat.
Stomach Neoplasms
Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Stomach Neoplasms
Gastric and intestinal phenotypes of gastric carcinoma with reference to expression of brain (fetal)-type glycogen phosphorylase.
Stomach Neoplasms
PYGB Promoted Tumor Progression by Regulating Wnt/?-Catenin Pathway in Gastric Cancer.
Tetanus
Metabolic adaptation in phosphorylase kinase deficiency. Changes in metabolite concentrations during tetanic stimulation of mouse leg muscles.
Tremor
Convulsions as the etiology of lactic acidosis in acute diazinon toxicity in rats.
Tuberculosis
Duplicated gene clusters suggest an interplay of glycogen and trehalose metabolism during sequential stages of aerial mycelium development in Streptomyces coelicolor A3(2).
Tuberculosis
Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents.
Urethritis
Identification and characterization of immunogenic proteins of mycoplasma genitalium.
Urinary Incontinence
Stress urinary incontinence in women. III. Different tissue biochemistry in patients with concomitant detrusor instability. Preliminary report.
Vitamin B 12 Deficiency
Periodic acid-schiff-positive megaloblasts in pernicious anemia.
Vitamin B 6 Deficiency
Effect of vitamin B6 deficiency on the expression of glycogen phosphorylase mRNA in rat liver and skeletal muscle.
Vitamin B 6 Deficiency
The behavior of muscle phosphorylase as a reservoir for vitamin B6 in the rat.
Vitamin B 6 Deficiency
The effect of pyridoxine deficiency on liver and muscle phosphorylase.
Vitamin K Deficiency
[Skeletal muscle phosphorylase and hexokinase activity in vitamin K deficiency and the effect of several 6-hydroxychromane derivatives on changes in hexokinase activity]
Whooping Cough
Inhibition of epinephrine-induced glycogen phosphorylase activation by Bordetella pertussis vaccine in rats.
Whooping Cough
Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.